49th ASH^® Annual Meeting and Exposition
December 8-11, 2007

Georgia World Congress Center
Atlanta, Georgia

Abstracts | Important Dates | Schedule At-a-Glance | Special Lectures | Special Interest Sessions | Education Program | Education Spotlight Sessions | Scientific Program | Meet-the-Expert Sessions | Oral and Poster Sessions | Trainee Activities and Services | ASH Business Meeting | Social Events | Exposition | Registration | Hotel Accommodations | CME Credits | Attendee Services | Travel | Atlanta | ASH Publications and Meeting Materials | Meeting Rules and Regulations | Speaker Preparation and Conflict of Interest | Friday Satellite Symposia

Meet-the-Expert Sessions

11:15 a.m. - 12:15 p.m. on Saturday, December 8, and Sunday, December 9

This year, ASH has invited 54 experts from all over the world to facilitate informal discussions allowing participants to present their questions and gain new perspectives. These sessions will take place from 11:15 a.m. – 12:15 p.m., and ticket fees will include a box lunch for each attendee.

Ticket Prices (per session)
Member: $20
Non-Member: $30

Tickets are limited and only available on site on a first-come, first-served basis. Only one ticket per person is allowed. Meet-the-Expert sessions are restricted to registered medical professionals only; no businesspersons or media will be admitted. These tickets can be purchased at the Meet-the-Expert counter in the ASH registration area of the Georgia World Congress Center starting Thursday, December 6, during registration hours until all tickets are sold. The room assignment will be indicated on the ticket. Please check your ticket carefully to ensure proper date, time, location, and session choice.

Attention Trainees!
A number of tickets for the Meet-the-Expert Sessions will be reserved especially for trainees. Proof of status as an ASH Associate member or non-member in training will be required to purchase a ticket. Please show your name badge to the staff at the Meet-the-Expert ticket counter.

Saturday, December 8

Claudio Anasetti, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Alternative Donor Transplants

Kenneth C. Anderson, MD, Dana-Farber Cancer Institute, Boston, MA
Novel Treatment Paradigms in Multiple Myeloma

Jane F. Apperley, MB ChB, Hammersmith Hospital, Imperial College School of Medicine, London, United Kingdom
Treatment Options for Patients Failing Imatinib

Ernest Beutler, MD, The Scripps Research Institute, La Jolla, CA
Red Blood Cell Enzymopathies

Nicholas Chiorazzi, MD, The Feinstein Institute for Medical Research, Manhasset, NY
Prognostic Factors and Biology of Chronic Lymphocytic Leukemia B Cells

Joseph M. Connors, MD, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Diffuse Agressive Lymphoma

Eldad Dann, MD, Rambam Medical Center Blood Bank, Haifa, Israel
Massive Transfusion in Wartime

Volker Diehl, MD, University of Cologne, Cologne, Germany
New Treatment Strategies for Advanced-Stage Hodgkin Lymphoma

Adolfo A. Ferrando, MD, PhD, Institute for Cancer Genetics, Columbia University, NY
T-Cell Lymphoblastic Leukemia and Lymphoma: NOTCH and Beyond

James L.M. Ferrara, MD, University of Michigan, Ann Arbor, MI
Bone Marrow Transplantation: Graft vs. Host Disease

Charles W. Francis, MD, University of Rochester School of Medicine, Rochester, NY
Thromboprophylaxis in Hospitalized Patients

Patrick G. Gallagher, MD, Yale University, New Haven, CT
Red Cell Membrane Disorders: Neonatal Hematology

Ralph Green, MD, PhD, University of California, Davis Medical Center, Sacramento, CA
B12 and Folate Deficiencies: Changing Paradigms

Barbara A. Konkle, MD, University of Pennsylvania School of Medicine, Philadelphia, PA
Thrombophilic Disorders in Adults

Gary Kupfer, MD, Yale University School of Medicine, New Haven, CT
Biology of Fanconi Anemia

Eva Hellström-Lindberg, MD, PhD, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Management of Myelodysplastic Syndromes

Alexandra M. Levine, MD, City of Hope National Medical Center, Duarte, CA
Changing Patterns of Hematologic Malignancies Associated with HIV

Francesco Lo Coco, MD, Universita Tor Vergata, Rome, Italy
Genetic Diagnosis and Monitoring of Treatment Response in Acute Promyelocytic Leukemia

Selina Luger, MD, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA
Myelodysplasia: Treat or Transplant, Who, When, and How?

Oliver G. Ottmann, MD, University of Frankfurt, Frankfurt, Germany
Therapy of Philadelphia-Positive Acute Lymphocytic Leukemia

Loann Peterson, MD, Northwestern University Feinberg School of Medicine, Chicago, IL
Hematopathology of Lymphoproliferative Disorders

Josef T. Prchal, MD, University of Utah, Salt Lake City, UT
Clinical Features and Molecular Basis of Myeloproliferative Syndromes

Margaret V. Ragni, MD, MPH, University of Pittsburgh Medical Center and Hemophilia Center of Western Pennsylvania, Pittsburgh, PA
The Challenge of Clinical Research: Hemophilia and Company

Stephen E. Sallan, MD, Dana-Farber Cancer Institute, Boston, MA
Acute Lymphoblastic Leukemia in Children

Louis M. Staudt, MD, PhD, National Cancer Institute, National Institutes of Health, Bethesda, MD
Biology of Non-Hodgkin Lymphoma Revealed by Functional Genomics

Michael E. Williams, MD, University of Virginia Health System, Charlottesville, VA
Mantle Cell Lymphoma: New Insights and Novel Therapies

Leonard I. Zon, MD, Harvard University and Children’s Hospital Boston, Boston, MA
Hematopoietic Stem Cell Biology

Sunday, December 9

Frederick R. Appelbaum, MD, Fred Hutchinson Cancer Research Center, Seattle, WA
Post-Remission Therapy for Acute Myeloid Leukemia

George F. Atweh, MD, Mount Sinai School of Medicine, New York, NY
Translational Research in Sickle Cell Disease

Barry S. Coller, MD, Rockefeller University, New York, NY
The Joys and Challenges of Translational Research in the CTSA Era

James Downing, MD, St. Jude Children’s Research Hospital, Memphis, TN
Genomic Analysis of Acute Leukemia

Brian J. Druker, MD, Oregon Health and Science University Cancer Institute, Portland, OR
Current Management of Chronic Myeloid Leukemia

Carolyn A. Felix, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
Chromosomal Translocations in Acute Leukemias

Mark D. Fleming, MD, DPhil, Children’s Hospital Boston, Boston, MA
Genetics and Pathophysiology of Iron Metabolism Disorders

James N. George, MD, University of Oklahoma Health Sciences Center, Oklahoma City, OK
Thrombocytopenia

Steven D. Gore, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Epigenetic Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Jed Baron Gorlin, MD, MBA, Memorial Blood Center of Minnesota, St. Paul, MN
Plasma Transfusion: Its Use and Abuse – Impact of TRALI and Factor VIIa

Diane Krause, MD, PhD, Yale University School of Medicine, New Haven, CT
Plasticity of Bone-Marrow-Derived Stem Cells

Ross Levine, MD, Dana-Farber Cancer Institute, Boston, MA
JAK2 Mutations and Myeloproliferative Syndromes

Jonathan D. Licht, MD, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
Transcriptional Dysregulation in the Etiology of Acute Leukemias

Thomas P. Loughran, MD, Pennsylvania State University Cancer Institute, Hershey, PA
Diagnosis and Management of Large Granular Lymphocyte Leukemias

Susan O’Brien, MD, The University of Texas M.D. Anderson Cancer Center, Houston, TX
Chronic Lymphocytic Leukemia

Robert Z. Orlowski, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC
Novel Approaches to Therapy of Multiple Myeloma

Mortimer Poncz, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
How to Prevent Chemotherapy-Induced Thrombocytopenia

David Porter, MD, The University of Pennsylvania Medical Center, Philadelphia, PA
Graft-vs-Leukemia Effects of Bone Marrow Transplantation, Donor Leukocyte Infusion, and More

Bayard L. Powell, MD, Wake Forest University School of Medicine, Winston Salem, NC
Acute Promyelocytic Leukemia

Cindy Schwartz, MD, Warren Alpert Medical School of Brown University, Providence, RI
Pediatric Hodgkin Disease

Donald Small, MD, PhD, Johns Hopkins University, Baltimore, MD
FLT3 Inhibitors

Kim Smith-Whitley, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
Transfusion Therapy for Patients with Sickle Cell Disease

John M. Timmerman, MD, University of California Los Angeles Medical Center, Los Angeles, CA
Vaccination Strategies in Non-Hodgkin Lymphoma

Loren D. Walensky, MD, PhD, Dana-Farber Cancer Institute, Boston, MA
Targeting Apoptosis by Chemical Design

Philip Wells, MD, Ottawa Hospital Civic Site, Ottawa, Ontario, Canada
Advances in the Treatment of Venous Thromboembolism

Jane N. Winter, MD, Northwestern University, Chicago, IL
Controversies in the Treatment of Follicular Lymphoma

Neal S. Young, MD, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Marrow Failure